BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

161 related articles for article (PubMed ID: 26527150)

  • 1. Structural insights into the interaction of human IgG1 with FcγRI: no direct role of glycans in binding.
    Oganesyan V; Mazor Y; Yang C; Cook KE; Woods RM; Ferguson A; Bowen MA; Martin T; Zhu J; Wu H; Dall'Acqua WF
    Acta Crystallogr D Biol Crystallogr; 2015 Nov; 71(Pt 11):2354-61. PubMed ID: 26527150
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Structural mechanism of high affinity FcγRI recognition of immunoglobulin G.
    Lu J; Sun PD
    Immunol Rev; 2015 Nov; 268(1):192-200. PubMed ID: 26497521
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Structure of FcγRI in complex with Fc reveals the importance of glycan recognition for high-affinity IgG binding.
    Lu J; Chu J; Zou Z; Hamacher NB; Rixon MW; Sun PD
    Proc Natl Acad Sci U S A; 2015 Jan; 112(3):833-8. PubMed ID: 25561553
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Crystal structure of Fcγ receptor I and its implication in high affinity γ-immunoglobulin binding.
    Lu J; Ellsworth JL; Hamacher N; Oak SW; Sun PD
    J Biol Chem; 2011 Nov; 286(47):40608-13. PubMed ID: 21965667
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Structural basis for binding of human IgG1 to its high-affinity human receptor FcγRI.
    Kiyoshi M; Caaveiro JM; Kawai T; Tashiro S; Ide T; Asaoka Y; Hatayama K; Tsumoto K
    Nat Commun; 2015 Apr; 6():6866. PubMed ID: 25925696
    [TBL] [Abstract][Full Text] [Related]  

  • 6. CD16a with oligomannose-type
    Subedi GP; Barb AW
    J Biol Chem; 2018 Oct; 293(43):16842-16850. PubMed ID: 30213862
    [TBL] [Abstract][Full Text] [Related]  

  • 7. A Method to Detect the Binding of Hyper-Glycosylated Fragment Crystallizable (Fc) Region of Human IgG1 to Glycan Receptors.
    Blundell P; Pleass R
    Methods Mol Biol; 2019; 1904():417-421. PubMed ID: 30539483
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The high-affinity receptor for IgG, FcγRI, of humans and non-human primates.
    Chenoweth AM; Trist HM; Tan PS; Wines BD; Hogarth PM
    Immunol Rev; 2015 Nov; 268(1):175-91. PubMed ID: 26497520
    [TBL] [Abstract][Full Text] [Related]  

  • 9. High affinity IgG binding by FcgammaRI (CD64) is modulated by two distinct IgSF domains and the transmembrane domain of the receptor.
    Harrison PT; Allen JM
    Protein Eng; 1998 Mar; 11(3):225-32. PubMed ID: 9613847
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The many faces of FcγRI: implications for therapeutic antibody function.
    Swisher JF; Feldman GM
    Immunol Rev; 2015 Nov; 268(1):160-74. PubMed ID: 26497519
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The immunoglobulin G1 N-glycan composition affects binding to each low affinity Fc γ receptor.
    Subedi GP; Barb AW
    MAbs; 2016; 8(8):1512-1524. PubMed ID: 27492264
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Conformational effects of N-glycan core fucosylation of immunoglobulin G Fc region on its interaction with Fcγ receptor IIIa.
    Sakae Y; Satoh T; Yagi H; Yanaka S; Yamaguchi T; Isoda Y; Iida S; Okamoto Y; Kato K
    Sci Rep; 2017 Oct; 7(1):13780. PubMed ID: 29062024
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The 3.2-A crystal structure of the human IgG1 Fc fragment-Fc gammaRIII complex.
    Sondermann P; Huber R; Oosthuizen V; Jacob U
    Nature; 2000 Jul; 406(6793):267-73. PubMed ID: 10917521
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The second and third extracellular domains of FcgammaRI (CD64) confer the unique high affinity binding of IgG2a.
    Hulett MD; Hogarth PM
    Mol Immunol; 1998 Oct; 35(14-15):989-96. PubMed ID: 9881694
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Structural characterization of a mutated, ADCC-enhanced human Fc fragment.
    Oganesyan V; Damschroder MM; Leach W; Wu H; Dall'Acqua WF
    Mol Immunol; 2008 Apr; 45(7):1872-82. PubMed ID: 18078997
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Structural analysis of Fc/FcγR complexes: a blueprint for antibody design.
    Caaveiro JM; Kiyoshi M; Tsumoto K
    Immunol Rev; 2015 Nov; 268(1):201-21. PubMed ID: 26497522
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Restricted motion of the conserved immunoglobulin G1 N-glycan is essential for efficient FcγRIIIa binding.
    Subedi GP; Hanson QM; Barb AW
    Structure; 2014 Oct; 22(10):1478-88. PubMed ID: 25199692
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Restricted processing of CD16a/Fc γ receptor IIIa
    Patel KR; Roberts JT; Subedi GP; Barb AW
    J Biol Chem; 2018 Mar; 293(10):3477-3489. PubMed ID: 29330305
    [TBL] [Abstract][Full Text] [Related]  

  • 19. In vitro glycoengineering of IgG1 and its effect on Fc receptor binding and ADCC activity.
    Thomann M; Schlothauer T; Dashivets T; Malik S; Avenal C; Bulau P; Rüger P; Reusch D
    PLoS One; 2015; 10(8):e0134949. PubMed ID: 26266936
    [TBL] [Abstract][Full Text] [Related]  

  • 20. FcγRI FG-loop functions as a pH sensitive switch for IgG binding and release.
    Lu J; Spencer M; Zou Z; Traver M; Brzostowski J; Sun PD
    Front Immunol; 2023; 14():1100499. PubMed ID: 36814926
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.